Therapeutic Candidate
CytoDyn Takes Steps towards a Brighter Future
Cyrus Arman, Ph.D.
CytoDyn
PAO-02-23-CL-04Feb 06, 2023
Licensing
Gilead Licenses Antiviral Candidates from Novartis
Nice Insight
PAO-M08-19-NI-019Aug 15, 2019
Drug Candidate
Inflammatory Disease Candidate Reaches End of the Line
Nice Insight
PAO-M08-19-NI-017Aug 15, 2019
Licensing
Cumulus Oncology Licenses Chk1 Kinase Inhibitor Candidate from Ligand
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-025May 29, 2019
Vaccine
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
Inovio Pharmaceuticals, Inc.
PR-M05-19-NI-074May 28, 2019
Drug Design
Computer-Aided Drug Design Leads to Real Candidate and New Biotech Startup
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-19-NI-024Jan 30, 2019
Drug Candidate
Prometic Presents New Data on NASH Drug Candidate PBI-4547
Prometic
PR-M06-18-NI-080Jun 25, 2018
Biologic Candidates
Addressing Development Challenges for Complex Biologic Drug Candidates
Karen Fallen
Lonza
PAP-Q2-18-CL-004May 29, 2018
Drug Candidate
STA Pharmaceutical Co. to Manufacture Phoenix Molecular Designs’ Anticancer Candidate
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-18-NI-018Apr 26, 2018
Product Pipeline
Moderna Announces 19 Development Candidates at JPM
Guy Tiene
Nice Insight
PAO-M01-18-NI-021Jan 12, 2018
CFDA
China FDA Publishes Guidance for Priority Review
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-18-NI-013Jan 09, 2018